ACTU Insider Trading

Insider Ownership Percentage: 19.90%
Insider Buying (Last 12 Months): $4,000,000.00
Insider Selling (Last 12 Months): $374,991.00

Actuate Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Actuate Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Actuate Therapeutics Share Price & Price History

Current Price: $8.19
Price Change: Price Increase of +0.19 (2.38%)
As of 09/19/2024 06:26 PM ET

This chart shows the closing price history over time for ACTU up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Actuate Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/14/2024Equity Cof Lp BiosDirectorBuy500,000$8.00$4,000,000.001,259,427View SEC Filing Icon  
8/14/2024Leslie W KreisMajor ShareholderSell24,999$9.00$224,991.00131,248View SEC Filing Icon  
8/14/2024Todd S ThomsonInsiderSell18,750$8.00$150,000.001,184,795View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Actuate Therapeutics (NASDAQ:ACTU)

78.29% of Actuate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Actuate Therapeutics logo
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.
Read More on Actuate Therapeutics

Today's Range

Now: $8.19
Low: $8.00
High: $8.19

50 Day Range

MA: N/A

52 Week Range

Now: $8.19
Low: $7.33
High: $10.16

Volume

4,560 shs

Average Volume

38,033 shs

Market Capitalization

$156.51 million

P/E Ratio

54.60

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Actuate Therapeutics?

Actuate Therapeutics' top insider shareholders include:
  1. Equity Cof Lp Bios (Director)
  2. Todd S Thomson (Insider)
  3. Leslie W Kreis (Major Shareholder)
Learn More about top insider investors at Actuate Therapeutics.